While major drugmakers tussle for market supremacy, they are also taking on compound pharmacies that have not stopped selling obesity drugs despite the end of the shortage of such drugs.

LLY's Mounjaro and Zepbound drove 56% of revenues in 2025 as obesity demand surged, with new launches and Medicare access set to fuel growth.

Zepbound (tirzepatide) and Mounjaro (tirzepatide) are prescription drugs used to treat different conditions. Zepbound and Mounjaro are not available as generic drugs. The two drugs have some ...

Zepbound (tirzepatide) and Ozempic (semaglutide) are brand-name subcutaneous injections. They’re both prescribed for weight loss and weight management, but only Zepbound has been FDA-approved for this ...

There’s no question that medications like semaglutide (Wegovy) and tirzepatide (Zepbound) make headlines. They’re two of the handful of medications approved specifically for weight loss. While both ...